This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (30)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Genetic Disorders  • HIV/AIDS  • Amyotrophic Lateral Sclerosis  • Review  • Motor Neuron Disease  • Movement Disorders  • Neuromuscular diseases  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic

A Critical Review of the Literature

Richard S. Bedlack, MD, PhD; Warren J. Strittmatter, MD; Joel C. Morgenlander, MD

Arch Neurol. 2000;57:1561-1565.

Molecular mechanisms that alter the incidence and rate of neuromuscular disease progression are, in many cases, only partially understood. Several recent studies have asked whether apolipoprotein E (apoE for the protein, APOE for the gene) influences these aspects of specific neuromuscular disorders, as it does in central nervous system disorders such as Alzheimer disease. Although these studies are open to methodological criticism, several interesting trends have emerged. First, the APOE4 allele seems to be associated with an increased risk for developing certain neuromuscular diseases, including diabetic neuropathy and human immunodeficiency viral neuropathy. Second, this allele appears to be associated with faster progression of some neuromuscular diseases, including diabetic neuropathy and possibly motor neuron disease. Third, the APOE2 allele seems to confer protection against developing certain neuromuscular diseases, including the amyotrophic lateral sclerosis (ALS)/parkinsonism/dementia complex of Guam. Finally, this allele is associated with a better prognosis in neuromuscular diseases such as motor neuron disease. The effect of various APOE alleles on neuromuscular diseases therefore parallels their influence on central nervous system diseases.

From the Division of Neurology, Duke University Medical Center, Durham, NC.

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(11):1661-1662.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Apolipoprotein E Gene Polymorphisms and Retinal Vascular Signs: The Atherosclerosis Risk in Communities (ARIC) Study
Liew et al.
Arch Ophthalmol 2007;125:813-818.
ABSTRACT | FULL TEXT  

Impaired reinnervation in HIV infection following experimental denervation
Hahn et al.
Neurology 2007;68:1251-1256.
ABSTRACT | FULL TEXT  

The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angle Glaucoma
Ressiniotis et al.
Arch Ophthalmol 2004;122:258-261.
ABSTRACT | FULL TEXT  

Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome
Pritchard et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:971-973.
ABSTRACT | FULL TEXT  

APOE genotype is a risk factor for neuropathy severity in diabetic patients
Bedlack et al.
Neurology 2003;60:1022-1024.
ABSTRACT | FULL TEXT